top of page

Abstract Submissions

Online submission for the upcoming Barts Research and Advanced Interventional Neuroradiology (B.R.A.I.N) Conference is now open. Each abstract will be scored by at least two reviewers and all abstracts will be accepted on the basis of scientific merit.
26 November 2020
1 December 2020
3 December 2020
Download Abstract Submission Guidelines

Please note any accepted presenter will receive a 10% reduction in cost from conference delegate rate.


Abstract Themes

  • Aneurysms

  • Stroke

  • ICAD, Tumours and other

  • Embryology, Phylogeny, AVM and DAVF

  • Other topics of interest to the interventional neuroradiology community


There is a maximum of 3 abstract submissions per person allowed.

If successful you will be invited to either give a in-person presentation as part of the main programme or be asked to provide a short video or PowerPoint presentation which will be shared in the e-learning area.


Rules for Authors


Prior Publication of Material:
The B.R.A.I.N conference is a forum for the presentation of novel research findings. The work covered by the abstract must not have been published (manuscript or abstract) before December 7th 2020. If the work has been presented at another meeting, the author must disclose when and where it was presented (during submission process). This is so the Abstract Review Committee can make its decision based on all available details.



We are committed to offering participants an open forum for scientific discussion, wherein all scientists and clinicians are invited to contribute actively. To preserve this valuable environment, the organising committee urges all presenters to avoid statements, symbols or other displays that are subjective and unscientific in nature.


Abstract Acceptance:

Each abstract will be scored by at least two reviewers. Abstract will be accepted on the basis of scientific merit. If you abstract is accepted and you are invited to present in person there will be a 10% reduction on your conference fee. A repository of talks given at the conference will be used at a later date for viewing to people who sign up to future conferences and webinars.


Abstract Revisions:

Abstracts my not be revised or resubmitted after the deadline of 26th November 2020.


Abstract Withdrawal:

Please submit abstract withdrawal requests in writing by 26th November 2020.

Change of Presenting Author:
Please submit requests in writing by 26th November 2020. After this date, changes will no longer appear on the programme or website.  


Preparation of Abstracts


Abstracts must be written and presented in English. Careful typing and proof-reading are essential.

Word Count:

Abstracts should not exceed 500 words.

Abstract Themes:

To ensure that your abstract receives proper scientific consideration, be sure to note the appropriate abstract theme as indicate below:

  • Aneurysms

  • Stroke

  • ICAD, Tumours and other

  • Emryology, Phylogeny, AVM and DAVF

  • Other topics of interest to the interventional neuroradiology community

Digital Video Submissions:
Content – all digital videos must be recorded in English and have some sound. The opening of the presentation should begin with the title and all the authors’ full names. It is important that all videos must be accompanied by a written abstract.

Length – all videos must not exceed 8 minutes in total length. Any videos that are longer than 8 minutes in durations will be automatically rejected.

Format and Quality – It is important that the overall quality of the video is as high as possible. All submitted videos will be reviewed initially for picture and sound quality. Any videos that have poor sound and picture quality will be excluded from consideration regardless of the quality of content.

File Type and Size – The preferred format for video submission is MP4 as this has the strongest quality. We can also accept PowerPoint presentations with video embedded into the presentation. Please consider compressing or “zip” video files before uploading to the Abstract site for a quicker upload.


Drug Names

Please use generic drug names in your abstract submission.
Standard abbreviations may be used without definition. Non-standard abbreviations should be kept to a minimum and placed in parentheses after the first use of the word or phrase.

Abstract Title:

Abstracts must have a short, specific title (no abbreviations) that indicates the nature of the investigation.

Abstracts MUST include the following four distinct sections:
- Introduction and Objective
- Materials and Methods
- Results
- Conclusion


Do not include any references, credits or grant support


Abstract Data:

Authors should not “split” data to create several abstracts from one. If splitting is judged to have occurred, priority scores of related abstracts will be reduced.

Abstracts containing identical or nearly identical data submitted from the same institution (and/or individuals) describing the same study population will be disqualified.

Statements such as “results will be discussed” will automatically disqualify the abstract. Reviewers require specific data on which to base their evaluation. Please bear in mind that your abstract will be rated according to the following criteria:

  • Is the design of the study valid?

  • Are the methods appropriate?

  • What is the significance of the results?

  • Is the event described in the case report significant?

Human Experimentation:

Any human experimentation conducted as part of the submitted abstract(s) must follow the protocol approved by the institutional or local committee on ethics in human investigation, or, if no such committee exists, the investigation should have been conducted in accordance with the principles of the World Medical Association’s Helsinki Declaration. The Organising Committee may inquire further into ethical aspects when evaluating the abstract(s).

bottom of page